Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_assertion type Assertion NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_head.
- NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_assertion description "[We examined the effects of low- and high-dose telmisartan, an angiotensin II receptor blocker, in rats with progressive anti-Thy1.1 mesangioproliferative glomerulonephritis in a clinically relevant situation of established renal damage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_provenance.
- NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_assertion evidence source_evidence_literature NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_provenance.
- NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_assertion SIO_000772 23192593 NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_provenance.
- NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_assertion wasDerivedFrom befree-20150227 NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_provenance.
- NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_assertion wasGeneratedBy ECO_0000203 NP737072.RAtPhC8_VLdp6LyyaI1wiS6wlegxKQ0IUQTilox6PsqK0130_provenance.